3Blank M,Choen J,Toder V,et al.Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies[J].Proc Natl Acad Sci,1991,88(8):3069.
4Fishman P,Falach-Vaknine E,Zigelman R,et al.Prevention of fetal loss in experimental antiphos-pholipid syndrome by in vivo administration of recombinant interleukin-3[J].Rapid Publication,1993,91(4):1834.
5Ikematsu W,Luan FL,La Rosa L,et al.Human anti cardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice[J].Arthritis Rheum,1998,41(6):1026.
8Holers VM,Girardi G,Mo L,et al.Complement C3 activation is required for antiphospholipid antibody induced fetal loss[J] ,Exp Med,2003,195(2):211.
9Berman J,Girardi G,Salmon J,et al.TNF-αis a critical effector and a ta-rget for therapy in antiphospholipid antibody induced pregnancy loss[J].Immunology,2005,174(1):485.
10Chen XX,Gu YY,Li SJ,et al.Some plasmin induced antibodies bind to cardiolipin,display lupusanticoagulant activity and induce fetal loss in mice[J].Immunology,2007,178:5351.
4HolersVM, Girardi L, Mo L, et al.Complement C3 activation is required for antiphospholipid antibody - induced fetal loss. J. Exp Med, 2002, 195 (2): 211-220
5Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclenal antibodies.Proc.NatI.Acad Sci.U.S.A.1991: 88:3069-3073
6Piona A, et al.Placental thrombosisis and fetal loss after passive transfer of mouse lupusmonoclonal or human polyclonal anti - cardiolipin antibodies in pregnant naive BALB/c mice.Stand J.Immunol. 1995: 41:427 - 423
7Ikematsu W, et al.Human anticardiolipin monoelonal autoantibodies cause placental ncrosis and fetal loss in BALB/c mice.ArthJltis Rheum. 1998: 41: 1026- 1039
8Rodger LB. Prefertilization gamete maturation events in marsupials.Medical Clinics of North America, 1994, 78:667.
9Bick RL. Baker WF. Anticardiolipin antibiodies and thrombosis.Hematol Oncol Clin Nor Am, 1992,6(6): 1287.
2Chen L, Quao S,Li H,et al. A comparison of endometrial and subendometrial vascularity' assessed by three-dimensional uhrasonography and power Doppler angiography between healthy fertile women and women with unexplained primary recurrent miscarriage[J]. Fertil Steril,2011,95(3) :1127-1129.
3Clark P,Walker ID,Lanshorue P,et al. SPIN( Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage[J]. Blood,2010,115 (21) :4162-4167.
4Cavalcante MB, Costa FD, Araujo JE, et al. Risk factors associated with a new pregnancy loss and perinatal out- comes in cases of recurrent miscarriage treated with lymphocyte immunotherapy[J]. J Matern Fetal Neonatal Med,2014,7(9) .. 1-3.
5Bahadori M, Zarei S, Zarnani AH, et al. IL-6, IL-10 and IL-17 gene polymorphisms in iranian women with recur- rent miscarriagerJT. Iran J Immunol, 2014,11 (2) : 97-104.
6Kumar A. Immunomodulation in recurrent miscarriage [J]. J Obstet Gynaecol India,2014,64(3) :165-168.
7Kit Y, Starykovych M, Va}rychova M, et al. Detection of novel auto-antigens in patients with recurrent miscar- riage:description of an approach and preliminary findings [J]. Croat Med J,2014,55(3) ~259-264.
8Harpham M, Abbott J. Use of a hysteroscopic morcellator to resect miscarriage in a Woman with recurrent asher- man's syndrome[J]. J Minim Invasive Gynecol, 2014,21 (6) :1118-1120.
9Dempsey MA, Flood K, Burke N, et al. Perinatal out- comes of women with a prior history of unexplained re- current miscarriage[J]. J Matern Fetal Neonatal Med, 2014,6 (4) ~ 1-4.
